Innocan Pharma Corp - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for Innocan Pharma Corp are displayedin the table. This webpage displays a free ESG analysis covering Innocan Pharma Corp. Scroll down to the bottom of this webpage for potential risks for Innocan Pharma Corp based on industry, location and marketcap.
Innocan Pharma Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.7, social score of 1.6 and governance score of 4.0.
2.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Innocan Pharma Corp | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Innocan Pharma Corp have an accelerator or VC vehicle to help deliver innovation?
Does Innocan Pharma Corp disclose current and historical energy intensity?
Does Innocan Pharma Corp report the average age of the workforce?
Does Innocan Pharma Corp reference operational or capital allocation in relation to climate change?
Does Innocan Pharma Corp disclose its ethnicity pay gap?
Does Innocan Pharma Corp disclose cybersecurity risks?
Does Innocan Pharma Corp offer flexible work?
Does Innocan Pharma Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Innocan Pharma Corp disclose the number of employees in R&D functions?
Does Innocan Pharma Corp conduct supply chain audits?
Does Innocan Pharma Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Innocan Pharma Corp conduct 360 degree staff reviews?
Does Innocan Pharma Corp disclose the individual responsible for D&I?
Does Innocan Pharma Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Innocan Pharma Corp disclose current and / or historical scope 2 emissions?
Does Innocan Pharma Corp disclose water use targets?
Does Innocan Pharma Corp have careers partnerships with academic institutions?
Did Innocan Pharma Corp have a product recall in the last two years?
Does Innocan Pharma Corp disclose incidents of discrimination?
Does Innocan Pharma Corp allow for Work Councils/Collective Agreements to be formed?
Has Innocan Pharma Corp issued a profit warning in the past 24 months?
Does Innocan Pharma Corp disclose parental leave metrics?
Does Innocan Pharma Corp disclose climate scenario or pathway analysis?
Does Innocan Pharma Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Innocan Pharma Corp disclose the pay ratio of women to men?
Does Innocan Pharma Corp support suppliers with sustainability related research and development?
Does Innocan Pharma Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Innocan Pharma Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Innocan Pharma Corp involved in embryonic stem cell research?
Does Innocan Pharma Corp disclose GHG and Air Emissions intensity?
Does Innocan Pharma Corp disclose its waste policy?
Does Innocan Pharma Corp report according to TCFD requirements?
Does Innocan Pharma Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Innocan Pharma Corp disclose energy use targets?
Does Innocan Pharma Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Innocan Pharma Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Innocan Pharma Corp
These potential risks are based on the size, segment and geographies of the company.
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.